The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells.

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Nature Immunology (Impact Factor: 24.97). 06/2011; 12(6):536-43. DOI: 10.1038/ni.2037
Source: PubMed

ABSTRACT The transcription factor BATF controls the differentiation of interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) by regulating expression of the transcription factor RORγt itself and RORγt target genes such as Il17. Here we report the mechanism by which BATF controls in vivo class-switch recombination (CSR). In T cells, BATF directly controlled expression of the transcription factors Bcl-6 and c-Maf, both of which are needed for development of follicular helper T cells (T(FH) cells). Restoring T(FH) cell activity to Batf(-/-) T cells in vivo required coexpression of Bcl-6 and c-Maf. In B cells, BATF directly controlled the expression of both activation-induced cytidine deaminase (AID) and of germline transcripts of the intervening heavy-chain region and constant heavy-chain region (I(H)-C(H)). Thus, BATF functions at multiple hierarchical levels in two cell types to globally regulate switched antibody responses in vivo.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Understanding germinal center reactions is crucial not only for the design of effective vaccines against infectious agents and malignant cells but also for the development of therapeutic intervention for the treatment of antibody-mediated immune disorders. Recent advances in this field have revealed specialized subsets of T cells necessary for the control of B cell responses in the follicle. These cells include follicular regulatory T cells and Qa-1-restricted cluster of differentiation (CD)8(+) regulatory T cells. In this review, we discuss the current knowledge related to the role of regulatory T cells in the B cell follicle.
    Immune Network 10/2014; 14(5):227-36.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sparse linear models approximate target variable(s) by a sparse linear combination of input variables. The sparseness is realized through a regularization term. Since they are simple, fast, and able to select features, they are widely used in classification and regression. Essentially linear models are shallow feed-forward neural networks which have three limitations: (1) incompatibility to model non-linearity of features, (2) inability to learn high-level features, and (3) unnatural extensions to select features in multi-class case. Deep neural networks are models structured by multiple hidden layers with non-linear activation functions. Compared with linear models, they have two distinctive strengths: the capability to (1) model complex systems with non-linear structures, (2) learn high-level representation of features. Deep learning has been applied in many large and complex systems where deep models significantly outperform shallow ones. However, feature selection at the input level, which is very helpful to understand the nature of a complex system, is still not well-studied. In genome research, the cis-regulatory elements in non-coding DNA sequences play a key role in the expression of genes. Since the activity of regulatory elements involves highly interactive factors, a deep tool is strongly needed to discover informative features. In order to address the above limitations of shallow and deep models for selecting features of a complex system, we propose a deep feature selection model that (1) takes advantages of deep structures to model non-linearity and (2) conveniently selects a subset of features right at the input level for multi-class data. We applied this model to the identification of active enhancers and promoters by integrating multiple sources of genomic information. Results show that our model outperforms elastic net in terms of size of discriminative feature subset and classification accuracy.
    2015 Annual International Conference on Research in Computational Molecular Biology (RECOMB), Warsaw, Poland; 04/2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Atherosclerosis is a chronic inflammatory arterial disease driven by both innate and adaptive immune responses to modified lipoproteins and components of the injured vascular wall. Specific T lymphocyte responses driven by T helper-1 or T regulatory cells play distinct and opposing roles in atherosclerosis. More recently, T helper-17 cells, which produce the prototype cytokine interleukin-17, have been characterized and shown to be critical in mucosal host defense against microbial and fungal pathogens. Sustained production of interleukin-17 in an inflammatory context has been linked to the pathology of several autoimmune and inflammatory diseases. However, regulatory and protective roles have also been reported in selective disease settings. Studies in atherosclerosis led to conflicting results on the roles of interleukin-17 and T helper-17 cells in disease development and plaque stability. The present review provides a summary of the available evidence and putative mechanisms linking this pathway to atherosclerosis, as well as a perspective on the risks and benefits of interleukin-17-targeted cytokine therapy in patients at high cardiovascular risk.
    Arteriosclerosis Thrombosis and Vascular Biology 09/2014; · 5.53 Impact Factor


Available from